Acetylation is the major metabolic pathway of isoniazid (INH) mediated by N-acetyltransferases (NATs). Previous reports suggest that slow acetylators have higher risks of INH hepatotoxicity than rapid acetylators, but the detailed mechanisms remain elusive. The current study used Nat1/2(À/À) mice to mimic NAT slow metabolizers and to investigate INH metabolism in the liver. We found that INH acetylation is abolished in the liver of Nat1/2(À/À) mice, suggesting that INH acetylation is fully dependent on NAT1/2. In addition to the acetylation pathway, INH can be hydrolyzed to form hydrazine (Hz) and isonicotinic acid (INA). We found that INA level was not altered in the liver of Nat1/2(À/À) mice, indicating that deficiency of NAT1/2 has no effect on INH hydrolysis. Because INH acetylation was abolished and INH hydrolysis was not altered in Nat1/2(À/À) mice, we expected an extremely high level of INH in the liver. However, we only observed a modest accumulation of INH in the liver of Nat1/2(À/À) mice, suggesting that there are alternative pathways in INH metabolism in NAT1/2 deficient condition. Our further studies revealed that the conjugated metabolites of INH with endobiotics, including fatty acids and vitamin B6, were significantly increased in the liver of Nat1/2(À/À) mice. In summary, this study illustrated that deficiency of NAT1/2 decreases INH acetylation, but increases the interactions of INH with endobiotics in the liver. These findings can be used to guide future studies on the mechanisms of INH hepatotoxicity in NAT slow metabolizers.
Introduction
Isoniazid (INH) is highly effective for tuberculosis therapy, but it frequently causes liver injury [1] . Although the detailed mechanisms of INH hepatotoxicity remain unknown [2] [3] [4] , INH metabolism has been thought to be associated with INH hepatotoxicity [5] [6] [7] . Acetylation is the predominant pathway in INH metabolism [8, 9] . INH acetylation produces acetylisoniazid (AcINH) that can be further hydrolyzed to generate isonicotinic acid (INA) and acetylhydrazine (AcHz) (Fig. 1) . Bioactivation of AcHz has been considered as a cause of INH-induced liver injury [5] [6] [7] . INH can also be hydrolyzed to produce INA and hydrazine (Hz) (Fig. 1) [9, 10] . Hz inhibits mitochondrial complex II and potentially causes mitochondrial injury [11] . In addition, INH itself has been found to undergo bioactivation and possibly lead to immune-mediated liver injury [12, 13] . Furthermore, INH can disturb endobiotic homeostasis in the liver, which may also contribute to INH hepatotoxicity [14] [15] [16] [17] .
N-acetyltransferase (NAT) is the key enzyme in INH metabolism, and it also contributes to Hz metabolism ( Fig. 1 ) [8] [9] [10] . Genetic status of NAT2, and hence the rate of INH acetylation, is associated with INH hepatotoxicity [5, [18] [19] [20] . It has been predicted that rapid acetylators should have a higher risk of liver injury than slow acetylators because of AcHz production [5, 20] . However, most clinical studies have found that the incidence of INH hepatotoxicity is higher in slow acetylators than rapid acetylators [19, [21] [22] [23] [24] . The goal of the current study is to determine the effect of NAT deficiency on INH metabolism in the liver. Our findings will provide the biochemical basis of INH hepatotoxicity in NAT slow metabolizers.
INH, Hz, AcHz, INA, 4-aminobenzoic acid, sulfamethazine, pyridoxal (PL), pyridoxal 5-phosphate (PLP), and 4-nitrophenol were purchased from Sigma-Aldrich (St. Louis, MO). AcINH was purchased from Toronto Research Chemicals (Toronto, ON, Canada). All solvents for metabolite analysis were of the highest grade commercially available.
Animals and treatments
Nat1/2(À/À) mice [25] and wild-type (WT) mice are on the C57BL/6 background. All mice were maintained under a standard 12 h dark/light cycle with water and chow provided ad libitum. These mice (6-8 weeks old, male, n = 3-4 in each group) were orally treated with vehicle or INH. The dose of INH was 50 mg/ kg, which was calculated based on the difference in body surface area between humans and mice [26] . After 0.25, 0.5, 1, 2, 4, or 8 h of INH treatment, the mice were sacrificed. Liver tissues were harvested and flash-frozen in liquid nitrogen, then stored at À80°C until further analysis. The procedures were in accordance with study protocols approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh.
Sample preparation
Liver samples were homogenized in ice-cold water (100 mg of liver in 500 ml of water). To 100 ml of each homogenate, 200 ml of acetonitrile:methanol (1:1, v/v) was added and followed by vortex (30 s) and centrifugation (15,000g for 10 min). The supernatant was transferred to a new Eppendorf vial for a second centrifugation (15,000g for 10 min). Afterward, 1.0 ml supernatant was injected to ultra-performance liquid chromatography coupled with time-offlight mass spectrometry (UPLC-TOFMS) (Waters, Milford, MA) for metabolites' analysis.
Determination of NAT1 and NAT2 activities in Nat1/2(À/À) mice
Liver cytosols were used for analyzing NAT1 and NAT2 activities. Sulfamethazine and 4-aminobenzoic acid were used as probes of NAT1 and NAT2, respectively [27] . In brief, the reaction system included liver cytosol (2 mg of protein/ml), 30 mM sulfamethazine or 4-aminobenzoic acid, 0.5 mM acetyl-coenzyme A, 1 mM EDTA, and 1 mM dithiothreitol in 100 ml of 1Â phosphate-buffered saline (PBS, pH 7.4). The incubations were conducted at 37°C for 30 min (NAT1 assay) or 10 min (NAT2 assay). The reaction mixtures were terminated by adding 100 ml of ice-cold acetonitrile. The samples were vortexed for 30 s and then centrifuged at 15,000g for 10 min. One ml supernatant was injected into UPLC-TOFMS for metabolite analysis.
2.5. Acetylation of Hz in liver cytosols of Nat1/2(À/À) mice
The reactions were performed with Hz (0.5 mM), acetyl-CoA (0.5 mM), 1 mM EDTA, and 1 mM dithiothreitol, and liver cytosol (1 mg protein/ml) in PBS. The reaction mixtures were incubated for 30 min at 37°C, and then terminated by adding 100 ml icecold acetonitrile. After vortex and centrifugation, the supernatant fractions were used to measure the acetylated product of Hz by UPLC-TOFMS.
2.6. CYP2E1 activity and expression in Nat1/2(À/À) mice
In addition to NAT, CYP2E1 is considered as an INH metabolizing enzyme [28, 29] . We therefore analyzed CYP2E1 expression and activity in the liver of Nat1/2(À/À) mice. Liver microsomes were used for analysis of CYP2E1 expression and activity. 4-nitrophenol was used as a probe for CYP2E1 activity assay [30] . CYP2E1 expression was analyzed by Western-blot (n = 3) [31] . The primary antibody against CYP2E1 was purchased from EMD Millipore (Billerica, MA; cat# AB1252).
Metabolite analysis by UPLC-TOFMS
INH and its metabolites were analyzed by UPLC-TOFMS using previously described methods with a low limit of quantitation at 1 ng/ml (except AcINH at 8 ng/ml) [17, 32, 33] . Briefly, metabolite analysis was performed on an Acquity UPLC BEH C18 column (2.1 Â 100 mm, 1.7 mm; Waters, Milford, MA). The flow rate of the mobile phase was 0.5 ml/min using a gradient ranging from 2% to 98% acetonitrile/water containing 0.1% formic acid. The column temperature was maintained at 50°C. TOFMS was operated in positive mode with electrospray ionization. The source and desolvation temperatures were set at 150°C and 500°C, respectively. Nitrogen was applied as cone and desolvation gas, and the gas flow rates were set as 50 l/h and 800 l/h, respectively. Argon was applied as the collision gas. Capillary and cone voltages were set at 0.8 kV and 40 V. TOFMS was calibrated with sodium formate and monitored by the intermittent injection of lockspray leucine encephalin. MS data were acquired in centroid format over a range of 50-1000 Da. Tandem mass spectrometry fragmentation was conducted with collision energy ramp ranging from 15 to 45 eV.
Synthesis of INH-PLP adduct
We proposed the formation of INH-PLP adduct in mouse liver. Thus, we synthesized this metabolite to verify its structure. Briefly, 100 ml of PLP (100 mM in H 2 O) and 100 ml of INH (100 mM in H 2 O) were added to an Eppendorf tube. The mixture was incubated at 37°C for 10 min. The obtained product was analyzed by UPLC-TOFMS.
Data analysis and statistics
Area under the concentration-time curve from 0 to 8 h (AUC 0-8h ) of INH and its metabolites, as well as INH-endobiotics conjugates, in the liver was calculated by noncompartmental analysis (Phoenix WinNonlin, version 6.4; Pharsight, Mountain View, CA). All quantification data are expressed as mean or mean ± SD. Statistical analysis was performed with two-tailed Student's t tests using Graphpad Prism 6 (Graphpad Software, San Diego, CA). A P value less than 0.05 was considered to be statistically significant.
Results

3.
1. Hepatic activities of NAT1, NAT2, and CYP2E1 in Nat1/2(À/À) mice As expected, both NAT1 and NAT2 activities were significantly suppressed in the liver of Nat1/2(À/À) mice ( Fig. 2A and B) . CYP2E1 is also thought to be involved in INH metabolism and hepatotoxicity [28, 29] . Therefore, we examined CYP2E1 expression and activity in the liver of Nat1/2(À/À) mice. We did not observe any differences in CYP2E1 expression and activity between the livers of WT and Nat1/2(À/À) mice ( Fig. 2C and D) .
INH acetylation in the liver of Nat1/2(À/À) mice
INH acetylation produces AcINH. Following INH administration, AcINH rapidly reached maximum concentration in the liver of WT mice (Fig. 3A) . In contrast, AcINH was not detected in the liver of Nat1/2(À/À) mice (Fig. 3A and B) . These data suggest that INH acetylation is fully dependent on NAT1/2.
INH hydrolysis in the liver of Nat1/2(À/À) mice
In addition to the acetylation pathway, INH can be hydrolyzed by amidases to form Hz and INA [2, 34, 35] . However, no significant difference was found in the hepatic level of INA between Nat1/2 (À/À) and WT mice following INH administration ( Fig. 4A and B) . In addition, the hepatic level of Hz only increased slightly in Nat1/2(À/À) mice when compared to WT mice ( Fig. 4C and D) . Furthermore, we compared amidase activity between WT and Nat1/2 (À/À) mice by incubating INH in liver microsomes, but no significant difference was observed in Hz formation (data not shown). These data indicate that NAT1/2 deficiency has no effect on amidase activity and INH hydrolysis.
Hz acetylation in the liver of Nat1/2(À/À) mice
Hz can be further acetylated to form AcHz and NAT2 is responsible for this metabolic pathway [35] . Therefore, we next measured AcHz in the liver of Nat1/2(À/À) mice. We found that AcHz concentration only decreased 35% in the liver of Nat1/2(À/À) mice when compared to WT mice ( Fig. 5A and B) . Because INH acetylation was fully abolished in the liver of Nat1/2(À/À) mice (Fig. 3) , AcHz cannot be produced from AcINH hydrolysis, but only from Hz acetylation. These data suggest that the mechanism of Hz acetylation is different from that of INH acetylation, and it is not exclusively dependent on NAT1/2. Consistent with the in vivo data, there was no significant difference in Hz acetylation in the liver cytosols of WT and Nat1/2(À/À) mice (Fig. 5C ), indicating that other isoforms of NAT are involved in Hz acetylation. 
INH levels in the liver of Nat1/2(À/À) mice
INH acetylation and hydrolysis are the major pathways in INH metabolism [2, 34] . Because INH acetylation was fully abolished and there was no change in INH hydrolysis (Figs. 3 and 4) , we expected a tremendous accumulation of INH in the liver of Nat1/2(À/À) mice. However, INH levels only increased 86% in the liver of Nat1/2(À/À) mice when compared to WT mice (Fig. 6 ). These data suggest there are alternative pathways in INH metabolism in addition to INH acetylation and hydrolysis.
INH-fatty acid interactions in the liver of Nat1/2(À/À) mice
INH can react with fatty acids to form INH-fatty acid amides [17] . Here, we found that the formation of INH-fatty acid amides 1 (m/z 402.3126) and 2 (m/z 400.2956) was significantly increased in the liver of Nat1/2(À/À) mice when compared to WT mice. The hepatic level of INH-fatty acid amide 1 reached maximum concentration at 1 h after INH administration in Nat1/2(À/À) mice (Fig. 7A) . Compared to WT mice, the AUC 0-8h of INH-fatty acid amide 1 increased 68% in the liver of Nat1/2(À/À) mice (Fig. 7B) . The hepatic level of INH-fatty acid amide 2 reached maximum concentration at 0.25 h after INH administration in Nat1/2(À/À) mice (Fig. 7C) . The AUC 0-8h of INH-fatty acid amide 2 was 84% higher in the liver of Nat1/2(À/À) mice than WT mice (Fig. 7D) .
INH-vitamin B6 (PL and PLP) interactions in the liver of Nat1/2(À/À) mice
PL and PLP are two major forms of vitamin B6. The hydrazine group in INH has been found to react with the aldehyde group in PL to form INH-PL adduct [17, 36] . We found that the formation of INH-PL adduct was significantly increased in the liver of Nat1/2(À/À) mice when compared to WT mice (Fig. 8A) , as the AUC 0-8h of hepatic INH-PL was twofold higher in Nat1/2(À/À) mice than WT mice (Fig. 8B) . In addition to INH-PL adduct, we found that INH can also react with PLP to form INH-PLP adduct. INH-PLP was eluted at 2.53 min (Fig. 8C) . The structure of INH-PLP was further elucidated by MS/MS fragment analysis and confirmed by comparing the retention time and MS/MS fragments with the synthetic standard (Fig. 8D) . The formation of INH-PLP adduct was also increased in the liver of Nat1/2(À/À) mice when compared to WT mice, especially at the 1 h and 2 h time points after INH treatment (Fig. 8E) . The AUC 0-8h of hepatic INH-PLP increased 48% in Nat1/2(À/À) mice when compared to WT mice (Fig. 8F) .
Discussion
The current study focused on the role of NAT1/2 in INH metabolism and disposition in mouse liver. Acetylation and hydrolysis are two known metabolic pathways of INH [2, 34, 35] . We found that deficiency of NAT1/2 totally abolished INH acetylation in the liver. Interestingly, suppression of INH acetylation does not promote INH hydrolysis, but increases the interactions of INH with endobiotics in the liver (Fig. 9) .
Our results support that NAT1/2 are critical in INH acetylation [2, 34, 35] . When NAT1 and 2 are deficient, INH acetylation is 100% suppressed in the liver. We expected that suppression of INH acetylation would promote INH hydrolysis. However, there was no change in INA, a metabolite of INH formed through hydrolysis, suggesting that blockage of the INH acetylation pathway has no effect on the INH hydrolysis pathway. Hz is also a metabolite of INH generated from hydrolysis. We found a 28% increase in Hz in the liver of Nat1/2(À/À) mice when compared to WT, which we believe is caused by the partial blockage of Hz acetylation, but not by the hydrolysis pathway (Fig. 9) .
Hz can be acetylated to form AcHz by NAT in the liver [2, 34, 35] . In addition, AcHz can be generated through the hydrolysis of AcINH. Since the formation of AcINH was fully blocked in the liver of Nat1/2(À/À) mice, AcHz cannot be produced through AcINH hydrolysis. Therefore, AcHz can only be generated from Hz acetylation in the liver of Nat1/2(À/À) mice. We found that the hepatic levels of AcHz only decreased 35% in Nat1/2(À/À) mice when compared to WT mice, suggesting that other NATs besides NAT1 and NAT2 are involved in Hz acetylation. These data suggest that the mechanism of Hz acetylation is different from INH acetylation.
It has been proposed that deficiency of NAT2 increases the risk of INH hepatotoxicity through the possible involvement of AcHz and Hz [19, 35] . AcHz is thought to undergo bioactivation and then lead to INH hepatotoxicity [5] [6] [7] . In addition, Hz was found to inhibit mitochondrial complex II and potentially cause mitochondrial injury [11] . By using Nat1/2(À/À) mice, we revealed that deficiency of NAT1/2 has no significant effect on AcHz or Hz levels in the liver, indicating that AcHz and Hz may not be critical for INH hepatotoxicity in NAT slow metabolizers.
As for INH itself, we expected a dramatic accumulation of INH in the liver of Nat1/2(À/À) mice because INH acetylation was 100% abolished and there was no increase in INH hydrolysis. However, we only observed an 86% increase in INH in the liver of Nat1/2 (À/À) mice when compared to WT mice, suggesting that INH undergoes alternative pathways of metabolism beyond acetylation and hydrolysis. Previous studies have shown that INH can interact with endobiotics in the liver to form adducts [15] [16] [17] . In the current study, we profiled the interactions of INH with fatty acids and vitamin B6 (PL and PLP) in the liver of Nat1/2(À/À) mice. We found that deficiency of NAT1/2 significantly increases the formation of INH-fatty acid amides, INH-PL, and INH-PLP adducts in the liver (Fig. 9) .
INH-fatty acid amides are produced through a replacement reaction, in which INH attacks fatty acyl-CoAs to form amides [17] . Fatty acyl-CoAs are intermediates in fatty acid b-oxidation [37] . The formation of INH-fatty acid amides indicates that INH can disturb fatty acid b-oxidation, which can therefore contribute to INH-induced microvesicular steatosis and INH hepatotoxicity [17, 38, 39] . In the current study, we observed higher levels of INH-fatty acid amides in the liver of Nat1/2(À/À) mice than WT mice, suggesting that deficiency of NAT1/2 promotes INHmediated disruption of fatty acid metabolism in the liver and potentiates INH-induced fatty liver.
Vitamin B6 has several forms including PL and PLP. Previous studies have shown that INH can react with PL to form INH-PL adduct [17, 36] . In addition to the INH-PL adduct, the current study illustrated the formation of INH-PLP adduct, indicating the interactions of INH with PLP. PLP is the active form of vitamin B6 and is the co-factor of various hepatic enzymes that are involved in the metabolic pathways of amino acids, glucose, lipids, etc. [40, 41] . Deficiency of vitamin B6 can disrupt cellular functions and lead to cytotoxicity [42] . INH can cause PLP deficiency and result in toxicity in the clinic, and supplementation of PL can attenuate the adverse effects of INH [36, 43] . The current study observed higher levels of INH-PL and INH-PLP in the liver of Nat1/2(À/À) mice than WT mice, suggesting that deficiency of NAT1/2 increases INHvitamin B6 interactions, which can potentiate vitamin B6 deficiency and increase the risk of liver dysfunction.
In summary, the current study used Nat1/2(À/À) mice to investigate INH metabolism in the liver. We confirmed that INH acetylation is dependent on NAT1/2. In addition, we found that: (i) deficiency of NAT1/2 has no effect on INH hydrolysis; (ii) deficiency of NAT1/2 does not dramatically change the levels of AcHz or Hz in the liver; and (iii) deficiency of NAT1/2 increases the interactions of INH with endobiotics in the liver (Fig. 9) . Our data also suggest that other NATs besides NAT1/2 are involved in Hz acetylation. These findings provide novel insights into INH metabolism in the liver under the NAT deficient condition, which can be used to guide future studies on the mechanisms of INH hepatotoxicity in NAT slow metabolizers.
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